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M2 is a minor component of the influenza A virus envelope. The cytoplasmic tail of the M2 protein is posttranslationally
modified in the infected cell by palmitylation and phosphorylation. The primary site for phosphorylation of the M2 cytoplasmic
tail is serine 64, which is highly conserved yet not required for the activity of the M2 ion channel. Using an exogenous
incorporation assay, we have shown that incorporation of M2 into virus particles is type-specific and does not require
phosphorylation of the cytoplasmic tail. In addition, phosphorylation of the cytoplasmic tail is not required for the directional
transport of M2 in polarized MDCK cells. Using a reverse genetics and reassortment procedure, we generated a virus (Ra)
specifically mutated in segment 7 such that the M2 cytoplasmic tail could no longer be phosphorylated. The virus was found
to grow as well as wild-type virus in tissue culture and in eggs, was stable on passage in these systems, and possessed no
second-site mutations in the engineered RNA segment. In vivo Ra replicated in Balb/c mice at least as well as the parent
strain A/WSN/33. These studies indicate that phosphorylation of the M2 cytoplasmic tail is not required for in vitro or in vivo
replication of influenza A virus. © 1998 Academic Press
INTRODUCTION
The M2 protein of influenza A virus is a small integral
membrane protein and a minor component of the virion
envelope (Lamb et al., 1985). M2 possesses an ion chan-
nel activity that is activated in the low pH environment of
the endosome after the virus enters the cell (Hay et al.,
1992; Pinto et al., 1992). The consequent acidification of
the virion interior stimulates the dissociation of the inter-
nal virus components in preparation for replication (Mar-
tin and Helenius, 1991). Influenza B and C viruses pos-
sess similar small membrane proteins, termed NB and
CM2, respectively (Betakova et al., 1996; Brassard et al.,
1996; Hongo et al., 1997; Pekosz and Lamb, 1997), which
may be functionally homologous to M2. However, these
proteins share no sequence homology and are encoded
by different strategies (Shaw and Choppin, 1984; Shih
and Krug, 1996; Yamashita et al., 1988).
M2 is translated from a spliced message derived from
RNA segment 7, which also encodes the matrix protein
M1 (Lamb et al., 1981). The M2 protein has an amino-
terminal ectodomain of 25 residues, which was recently
shown to be important for incorporation of the protein
into the influenza virus envelope (Park et al., 1998). The
transmembrane domain of 19 hydrophobic residues pos-
sesses the ion channel activity that can be blocked by
the antiviral agent amantadine (Duff et al., 1994). A func-
tion for the cytoplasmic tail of 54 amino acids has yet to
be assigned, although the length and sequence of this
region are well conserved among influenza A virus iso-
lates (Fig. 1a), suggesting that an evolutionary pressure
exists to maintain them. In particular, this region contains
a number of serine residues, which serve as sites for
phosphorylation, and a cysteine at residue 50, which
receives fatty acid modification (see Fig. 1a). However,
neither of these posttranslational modifications is re-
quired for the activity of the ion channel (Holsinger et al.,
1995; Pinto et al., 1992). The extreme carboxyl-terminal
four residues are completely conserved, and deletion of
a single amino acid from this terminus results in virus
attenuation. Furthermore, it has not been possible to
recover viruses with five or 10 residues deleted from the
C terminus (Castrucci and Kawaoka, 1995). In contrast,
the cytoplasmic tails of the other two virion envelope
proteins, haemagglutinin (HA) and neuraminidase (NA),
can be deleted both individually or simultaneously with-
out loss of virus viability (Garcia-Sastre and Palese, 1995;
Jin et al., 1997). Incorporation of HA into influenza parti-
cles is not a type-specific event because influenza A
virus HA proteins are incorporated into influenza B virus
particles after double infection of cells (Sklyanskaya et
al., 1985). Whether the NA proteins also show phenotypic
mixing is not known, although it is noteworthy that an
influenza A virus has been recovered in which the se-
quence of the cytoplasmic tail of NA was exchanged for
that of an influenza B virus NA protein (Bilsel et al., 1993).
The incorporation of M2 or NB proteins into heterotypic
particles has not previously been investigated.
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During influenza A virus infection, high levels of M2
accumulate at the surface of infected cells, yet the pro-
tein is present at low frequency in the virus envelope
(Zebedee and Lamb, 1988). This discrepancy implies that
only a subset of M2 molecules within the cell are incor-
porated into particles. In the current study, we asked
whether phosphorylation of the M2 cytoplasmic tail reg-
ulates incorporation of M2 molecules into particles and
hence controls viral assembly. We tested whether un-
phosphorylated M2 protein would be incorporated into
influenza virus particles in an exogenous incorporation
assay. In parallel, we examined whether the incorpora-
tion of M2 is type-specific by asking whether M2 can be
incorporated into influenza B virus particles. We have
also ascertained whether the phosphorylation status of
M2 affects its directional transport in polarized cells
because phosphorylation of other proteins has been
implicated in their targeting (Casanova et al., 1990; Jones
et al., 1995).
Finally, bearing in mind the acute sensitivity of the
virus to deletions of the M2 cytoplasmic tail and the
conservation of the posttranslational modifications in
this domain, we investigated whether a virus that con-
tained only unphosphorylated M2 could be isolated us-
ing a reverse genetics procedure.
RESULTS
Incorporation of exogenous M2 proteins into virus
particles
To detect incorporation of M2 protein into virus parti-
cles, we took advantage of the fact that the A/WSN/33
M2 migrates more slowly than M2 of A/PR/8/34 (Panay-
otov and Schlesinger, 1992) under nonreducing SDS–
PAGE. We established a Madin–Darby canine kidney
(MDCK) cell line that stably expresses the A/WSN/33 M2
protein. M2 expression at the cell surface was detected
by immunohistochemical staining using the 14C2 mono-
clonal antibody as primary antibody. The levels of ex-
pression of M2 protein in these cells were similar to
those found late in infection (Fig. 2a, lanes 6 and 7).
We next infected these cells with the A/PR/8/34 strain
of influenza A virus at a high m.o.i. and analyzed the
released virus for incorporation of exogenous M2 protein
by Western blot, also using 14C2 (Fig. 2a). In virus re-
leased from cells expressing the exogenous M2 protein,
FIG. 1. (a) Amino acid sequence alignment of the cytoplasmic tail domain of a number of M2 proteins. p, The site of fatty acid modification at cysteine
50. Serines that serve as sites for phosphorylation are indicated by arrows. Swiss-prot accession numbers are shown in bold. (b) Amino acid
sequences of the cytoplasmic tails of A/WSN/33 M2 and the phosphorylation mutant M2 proteins P-2 and P-1-2.
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we could clearly detect both a slow and a fast migrating
M2 species, indicating that the exogenous A/WSN/33 M2
protein had been incorporated (Fig. 2a, lane 2). When the
same cells were infected with B/Lee/40, no M2 was
detected in released virus (Fig. 2a, lane 4), although
incorporation of the functionally homologous type B pro-
tein NB was readily seen (Fig. 2b, lanes 1 and 2). NB is
visible as a single species in this experiment because
the glycosylated species in released virus have been
digested with endo-F and the B/Lee/40 infected cell
lysate used as a control was generated in the presence
of tunicamycin. These results demonstrate that incorpo-
ration of M2 protein into influenza virus particles is a
type-specific event.
The primary site for phosphate addition on the
A/Udorn/72 M2 cytoplasmic tail is at serine residue 64
(Holsinger et al., 1995). This residue, and the surrounding
consensus for modification, is conserved in the M2 se-
quences accumulated to date (Fig. 1a). It has been dem-
onstrated that modified M2 proteins. which are unable to
phosphorylate serine 64, use other serines for phosphor-
ylation (Holsinger et al., 1995). The A/WSN/33 M2 protein
contains two serines in the cytoplasmic domain at posi-
tions 64 and 71. To investigate the role of phosphate
moieties on the M2 cytoplasmic tail, we established
stable and clonal cell lines that expressed M2 proteins
mutated (by serine-to-alanine substitutions) at serine 71
(P-2) and at both serines 64 and 71 (P-1–2) (Fig. 1b). It is
interesting to note that we were not able to establish a
cell line expressing M2 mutated at serine 64 alone (P-1),
although we could detect expression of this protein after
transient transfection (data not shown).
After infection of cells expressing either the P-2 or
P-1–2 mutant M2 proteins, we monitored the M2 species
in released virus by Western blotting. Only tetrameric
FIG. 3. Analysis of A/PR/8/34 to detect incorporation of exogenous
wild-type and mutant M2s after infection of MDCK and MDCK cells
expressing wild-type M2 (MDCK-M2) or the mutant M2 proteins P-2
(MDCK-P-2) and P-1-2 (MDCK-P-1–2). Purified A/PR/8/34 was sub-
jected to 15% SDS–PAGE under nonreducing conditions and Western
blotting using 14C2 to detect M2. The migrations of the wild-type
A/WSN/33 and mutant M2 tetramers are indicated by the MDCK-M2 (a,
lane 6), MDCK-P-2 (a, lane 7), and MDCK-P-1-2 (b, lane 8) cell lysates.
The M2 tetramers of A/PR/8/34 are marked c (lane 9). A fourth species
of M2 (d), which runs with the expected mobility of M2 dimers, is
detected in the M2-expressing cell lysates and in the A/PR/8/34-
infected cell lysate (lanes 6–9). This species of M2 is absent from
purified virus (lanes 1–4). p, Cleaved species of both A/WSN/33 and
A/PR/8/34 M2 as described by Panayotov and Schlesinger (1992).
FIG. 2. Analysis of purified A/PR/8/34 and B/Lee/40 virus particles to
detect incorporation of exogenous A/WSN/33 M2. (a) Purified A/PR8/34
virus (lanes 1 and 2) or B/Lee/40 virus (lanes 3 and 4) were analyzed for
incorporation of exogenous M2 by 15% SDS–PAGE under nonreducing
conditions followed by Western blot using the 14C2 monoclonal anti-
body. M2 of A/WSN/33 migrates more slowly under these conditions
than the M2 of A/PR/8/34, and this difference is highlighted by analyz-
ing M2 oligomers. The migrations of A/WSN/33 M2 dimers and tetra-
mers are indicated by the lysate prepared from cells stably expressing
M2 (MDCK-M2) (lane 6, a). The migrations of the A/PR/8/34 M2 dimers
and tetramers are indicated by the A/PR/8/34 infected cell lysate (lane
7, b). No M2 species are detected in MDCK cells, which are neither
transfected or infected (lane 5) or have been infected with influenza
B/Lee/40 (lane 8). (b) Purified B/Lee/40 was analyzed by 20% SDS–
PAGE under denaturing conditions followed by Western blotting to
detect NB with polyclonal rabbit anti-NBHIS sera (lanes 1 and 2). The
migration of NB under these conditions is indicated by the B/Lee/40
infected cell lysate (lane 6). MDCK cells infected with B/Lee/40 were
incubated for 12 h in serum-free media containing 2.5 mg/ml tunicamy-
cin to prevent glycosylation of NB.
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forms of M2 are shown in Fig. 3 because the small
differences in migration between the M2 proteins are
more easily seen with this analysis. Both singly phos-
phorylated and unphosphorylated forms of M2 were
identified in released virions (Fig. 3, lanes 3 and 4). We
also analyzed whether the mutant M2s were incorpo-
rated into B/Lee/40 particles, and confirmed that as for
the wild-type protein, incorporation was type-specific
(data not shown).
Transport of M2 in polarized epithelial cells
The phosphorylation state of some proteins controls
directional transport in polarized epithelial cells
(Casanova et al., 1990; Jones et al., 1995). Wild-type M2 is
directed to the apical surface, where influenza virus
budding occurs (Hughey et al., 1992). To determine
whether phosphorylation plays a role in M2 targeting,
MDCK cells expressing either the wild-type or mutant M2
proteins were cultivated on DATA filters to allow selective
access to either the apical or basolateral surface. Sur-
face expression of M2 was determined by staining either
surface of the unfixed cells using 14C2. Staining was
detected only when the apical membranes had received
primary antibody, indicating that for both wild-type and
mutant M2 proteins, transport was exclusively directed
to the apical domain (Fig. 4). Thus phosphorylation of M2
does not influence directional transport and cannot ac-
count for the discrepancy in expression levels in the
infected cell compared with the amount of M2 incorpo-
rated into budding particles.
Generation of an M2 phosphate-minus mutant by
reverse genetics and analysis of phosphorylation
of its proteins
We next asked whether there may be a role for M2
phosphorylation that would be apparent only in the con-
text of the virus. We therefore attempted to rescue a
transfectant virus in which the serine residues at both
position 64 and 71 of A/WSN/33 M2 were replaced by
alanine. The A/WSN/33 M2 protein is naturally resistant
to the ion channel-blocking agent amantadine, and we
took advantage of this observation in designing a rescue
protocol. A synthetic RNA representing the mutated
P-1–2 segment was transfected as RNP complexes into
cells previously infected with an amantadine-sensitive
virus, A/Eng/42/72. Progeny transfectant viruses were
FIG. 4. Cell surface localization of wild-type M2 and the phosphorylation mutants P-2 and P-1-2. Cells were grown to confluency on DATA filters.
Surface distribution was determined by treating either surface of unfixed and nonpermeabilized cells with the 14C2 monoclonal antibody as a primary
antibody. This was followed by a b-galactosidase conjugated anti-mouse secondary antibody and, finally, incubation at 37°C with X-Gal substrate until
staining of the cell surfaces could be detected.
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selected in the presence of inhibitory concentrations of
amantadine. A silent change that creates a unique SacI
restriction enzyme site within codon 96 of the M2 mes-
sage was introduced into the cDNA such that viruses
derived from transfected RNAs could be identified by
cleavage of their segment 7 RT-PCR products by SacI. In
this way, a transfectant virus was identified in one of the
four plaques picked after transfection of the phosphate-
minus mutated RNA. Screening of the other three viruses
showed that they did not contain the tagging mutation,
and they are believed to be spontaneous escape mu-
tants of the helper virus that have gained resistance to
the antiviral agent (data not shown). The transfectant
virus was plaque purified three times in the presence of
amantadine and propagated in both MDCK cells and
eggs. Viral RNA from purified virus grown in cells or eggs
was used as template for RT-PCR of the entire segment
7 RNA. This product was cloned into pUC19 and se-
quenced. No changes were present in the RNA other
than those that had been engineered (data not shown).
The virus can grow to high titres in tissue culture and in
eggs and was stable over at least six passages in these
systems.
To confirm that the mutations introduced into the trans-
fectant virus did abolish phosphorylation of M2, we con-
ducted 32P-orthophosphate-labeling experiments of the
phosphate-minus virus and labeled proteins from the
helper A/Eng/42/72 and A/WSN/33 viruses as controls.
M2 and NP proteins were immunoprecipitated from ly-
sates of metabolically labeled infected cells. Fig. 5a
shows that although M2 from both A/Eng/42/72 and
A/WSN/33 viruses was labeled with 32P-orthophosphate
(lanes 2 and 4), M2 from the transfectant phosphate-
minus virus was not (lanes 1 and 3). A similar amount of
M2 was labeled with radioactive cysteine and methio-
nine for each virus (Fig. 5b, lanes 1–4), and orthophos-
phate labeling of NP was observed in all infected lysates
(Fig. 5a, lanes 6–9).
Isolation of a reassortant virus lacking
phosphorylation sites in M2 and growth
in Madin–Darby bovine kidney cells
The transfectant virus described above contained 7
segments derived from A/Eng/42/72 (H3N2) with seg-
ment 7 derived from A/WSN/33 (H1N1). It has been
previously observed that the M1 protein of H1 or H3
subtypes can affect growth of virus in tissue culture
(Yasuda et al., 1994). Therefore, to assess whether there
had been any subtle changes in phenotype as a result of
the phosphate-minus mutation in M2 and to distinguish
these from growth differences related to M1, we gener-
ated a reassortant virus Ra with the phosphate-minus
mutations in segment 7 in an A/WSN/33 background.
The plaques produced by the Ra virus at 37°C were
wild type in size and appearance. A multistep growth
curve of the Ra virus was generated after infection at
37°C of Madin–Darby bovine kidney (MDBK) cells at an
m.o.i. of 0.001 (Fig. 6). The virus showed no defect in
replication in these permissive cells in comparison with
the control virus A/WSN/33.
Growth of the Ra virus in vivo
To determine whether removal of the sites for phos-
phorylation of the M2 cytoplasmic tail affects the in vivo
replication and virulence of influenza A virus, 6-week-old
Balb/c mice were inoculated with Ra or the control strain
A/WSN/33. The weight and disease status of individual
mice were followed over an 7-day period. Both groups of
infected mice lost weight compared with age-matched
control animals at a similar rate (data not shown). Death
occurred slightly earlier in the mice infected with Ra
virus, and this difference was statistically significant by a
FIG. 5. Immunoprecipitation of M2 and NP from labeled infected cell
lysates. MDCK cells were infected with the phosphate-minus transfec-
tant virus (P-), the helper virus A/Eng/42/72, and A/WSN/33. Infected
cells were labeled using 32P-orthophosphate or 35S-methionine and
-cysteine. Cell lysates were immunoprecipitated either with a mono-
clonal antibody to NP or with 14C2. (a) Immunoprecipitation of 32P-
orthophosphate-labeled infected cell lysates with 14C2 (lanes 1–4) or
antibody to NP (lanes 6–9). (b) Immunoprecipitation of 35S-methionine
and -cysteine-labeled infected cell lysates with 14C2 (lanes 1–4) or
antibody to NP (lanes 6–9). As control, a B/Lee/40-infected cell lysate
was incubated with 14C2 antibody (B, a and b, lane 5).
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Student’s unpaired t test to a level of P , 0.005 (Table 1).
All infected animals were dead by 7 days after inocula-
tion with either virus.
On day 3 after virus administration, lungs were re-
moved from five mice infected with each virus, and the
amount of virus was quantified to assess the level of in
vivo replication of each virus (Table 1). The titres of virus
in the lungs of mice infected with Ra virus were ;0.5
log10-fold higher than in lungs of mice infected with
A/WSN/33 virus; again, this difference was significant
(P , 0.005). Three plaques of Ra virus isolated from the
lung of an infected mouse were amplified on MDBK cells,
and the viral RNA was extracted. Sequencing of the M2
cytoplasmic tail region of segment 7 of these viruses
revealed that there had been no reversion of the serine-
to-alanine mutations, nor indeed were there any other
changes of sequence in this region during in vivo repli-
cation (data not shown).
Taken together, these data indicate that the loss of
phosphorylation on the cytoplasmic tail of M2 has not
compromised the ability of the virus to replicate in the
mouse lung.
DISCUSSION
Six of the influenza A virus proteins (NP, NS1, NS2, M1,
PA, and M2) are reported to be phosphoproteins. The
phosphorylation state of NP and M1 is known to control
their intracellular distribution (Bui et al., 1996; Neumann
et al., 1997). Phosphorylation and dephosphorylation
events also control the direction of transport of cellular
proteins such as the polymeric immunoglobulin receptor
(pIgR) and the protease furin in polarized epithelial cells
(Casanova et al., 1990; Jones et al., 1995). Influenza
viruses bud exclusively from the apical membrane of
polarized cells, and it is known that M2, a structural
component of the virus, is transported predominately to
the apical side (Hughey et al., 1992). In this study, we
investigated the transport of M2 phosphorylation mu-
tants in polarized epithelial cells. By preventing phos-
phorylation at serine 71 or at both serines 64 and 71, no
differences in cell surface expression were seen (Fig. 4).
Furthermore, both the wild-type and mutant proteins
were transported to the cell surface at the same rate
(data not shown). We conclude that the phosphorylation
state of the cytoplasmic tail of M2 does not control its
intracellular transport.
Cytoplasmic tail phosphorylation on some proteins
can control their interactions with cytosolic components.
In the context of the influenza A virus M2 protein, such
interactions might be involved in viral assembly, possibly
through binding to the matrix protein M1. Earlier genetic
evidence had suggested a functional relationship be-
tween M2 and M1. The anti-M2 monoclonal antibody
14C2 was shown to inhibit virus budding (Hughey et al.,
1995). Furthermore, virus mutants that escape inhibition
by this M2-specific antibody have sequence changes in
either the M2 ectodomain (the antibody epitope), the M2
cytoplasmic tail, or M1 (Zebedee and Lamb, 1989). Inter-
estingly, one of the changes seen in the M2 cytoplasmic
tail was a mutation of the serine at position 71, a site in
the correct consensus for phosphorylation. It has also
been shown that the escape mutants with sequence
changes in M1 display a different morphology, suggest-
ing that the M1/M2 relationship might control virion mor-
phology (Roberts et al., 1998). On the other hand, in two
separate studies, coexpression of M2 (or HA or NA) did
not increase the proportion of M1 that associates with
membranes (Kretzschmar et al., 1996; Zhang and Lamb,
1996), whereas a third report showed that HA or NA
could enhance M1 membrane association (Enami and
Enami, 1996). The latter study did not assess the effect of
M2 coexpression.
We hypothesized that phosphorylation might control
TABLE 1
Replication and Pathogenicity of Wild-Type A/WSN/33 Influenza A
Virus or Ra M2 Phosphorylation Mutant Virus in Mice
Virus
Virus titre in the lung
as TCID50/lung
(number of animals)
Time to death
as h p.i.
(number of animals)
A/WSN/33 5.30 6 0.22 142.3 6 28.1
(n 5 5) (n 5 14)
Ra 5.81 6 0.19 117.0 6 16.7
(n 5 5) (n 5 16)
Note. Six week-old male Balb/c mice were infected intranasally with
25 ml of the A/WSN/33 virus or Ra virus containing 7.5 3 105 pfu. Virus
titres in the lungs were determined 3 days after infection by assaying
infectivity in MDBK cells. Values shown are mean 6 SD. Statistical
significance for the differences between A/WSN/33 and Ra effects was
calculated using a Student’s unpaired t test. For lung titres, this value
was P , 0.005, and for time to death, the value also was P , 0.005.
FIG. 6. Multistep growth analysis of the Ra reassortant virus com-
pared with wild-type A/WSN/33 virus in MDBK cells. MDBK cells were
infected with reassortant () or wild-type virus (F) at an m.o.i. of 0.001.
At various times after infection, cell supernatants were quantified by
end point titration in MDBK cells.
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incorporation of M2 into virus particles. However, we
show here that unphosphorylated M2 is efficiently incor-
porated into virus particles (Fig. 3, compare band a in
lane 2 with band b in lane 4). Furthermore, it is unlikely
that unphosphorylated M2 is incorporated by forming
hetero-oligomers with a phosphorylated species pro-
vided by the infecting A/PR/8/34 virus because we were
able to recover a transfectant virus whose M2 cannot be
phosphorylated. The amount of M2 incorporated into the
envelope of this recombinant virus is not different from
that for wild-type virus (data not shown). This result
confirms that phosphate is not required for M2 incorpo-
ration. It remains a possibility that phosphorylation actu-
ally prevents M2 incorporation. Indeed, some other en-
veloped viruses use a dephosphorylation event at the
plasma membrane to trigger the interaction of core com-
ponents with envelope proteins, enabling envelopment
and budding to occur. The E2 protein of Sindbis virus
requires phosphorylation to release its cytoplasmic tail
from the plasma membrane followed by a dephosphor-
ylation event, which allows the cytoplasmic tail to inter-
act with the nucleocapsid and assembly to occur (Liu
and Brown, 1993). In the case of duck hepatitis B virus,
assembly is believed to be a result of dephosphorylation
of the core protein because phosphorylated core protein
could not be detected in purified virions (Pugh et al.,
1989). To our knowledge, it has not been previously
demonstrated that the phosphorylated species of M2 is
incorporated into particles. Our preliminary experiments
demonstrated that 32P-orthophosphate-labeled M2 is as-
sociated with purified virions (data not shown). The issue
of how the levels of incorporation of M2 into the envelope
are controlled remains unresolved. Interestingly, it was
recently demonstrated that the HA transmembrane do-
main sequence determines its transport to specific areas
of the cell membrane termed sphingolipid rafts, which
differ in lipid composition from other plasma membrane
regions (Scheiffele et al., 1997). Presumably, these are
the sites of influenza virus assembly and budding. It may
be that M2 is not delivered efficiently to these areas and
thus not physically available for efficient incorporation
into particles along with HA and NA. This possibility is
currently under investigation. Regardless of the mecha-
nism, the virus has evolved to limit the amount of M2
allowed in the particle for a reason. It is tempting to
speculate that too many ion channels might overacidify
the virion interior with deleterious effects on the internal
proteins and the uncoating mechanism.
We demonstrated in this study that unlike the situation
for the other influenza A virus envelope proteins, HA and
NA, M2 incorporation into virions is type-specific. The NB
protein of influenza B virus is thought to be the functional
homolog of M2, although it is not phosphorylated (Bras-
sard and Lamb, 1996). Therefore, we tested whether an
unphosphorylated M2 protein would be incorporated into
influenza B virus envelopes. However, this was not the
case, suggesting that it is not the phosphate moiety but
specific sequences in M2 that direct the type-specific
incorporation. Indeed, a recent study by Park et al. (1998)
demonstrated that the M2 ectodomain is required for
incorporation of a chimeric protein into influenza A virus
particles. These authors hypothesized that this region of
M2 might interact with the HA ectodomain or transmem-
brane domain. To be compatible with the present data,
this model would require that M2 does not interact with
the equivalent sequences of influenza B virus HA.
In addition, we used a reverse genetics procedure to
generate a mutant virus that is unable to phosphorylate
the M2 cytoplasmic tail. Neither the transfectant virus nor
a reassortant virus (Ra) with the same mutated RNA
segment, could phosphorylate M2. In addition, the phos-
phate-minus viruses showed little phenotypic difference
in MDCK cells, MDBK cells, or eggs compared with
control viruses. It is likely that the pressures exerted on
viruses replicating in the whole host organism are differ-
ent from those in the highly permissive in vitro systems.
Indeed, the conservation of phosphorylation sites within
the M2 sequence over time suggests that there is an
advantage conferred by possessing phosphorylated M2
that has not been detected here. Other negative-strand
RNA viruses encode viral proteins or possess protein
modifications that are not essential for in vitro viability
(Bukreyev et al., 1997; Kato et al., 1997; Radecke and
Billeter, 1996; Sakaguchi et al., 1997). In some of these
cases, the mutation has subsequently been shown to
attenuate virus pathogenesis in vivo (Bukreyev et al.,
1997; Kato et al., 1997). In other situations, there was an
enhancement of replication or pathogenicity in mice. For
example, an influenza A virus lacking cysteine residues
in M2 replicated to higher titres in the mouse upper
respiratory tract (Castrucci et al., 1997), and an engi-
neered VSV in which the gene order was rearranged
killed mice at a lower dose than the wild type (Wertz et
al., 1997). It is conceivable that viruses that kill more
slowly have a subtle evolutionary advantage over more
pathogenic variants because the potential for transmis-
sion might be increased. Our studies have shown that
loss of phosphorylation on M2 has not compromised the
replication of influenza virus in vivo. Indeed, higher viral
titres were recovered from lungs of mice infected with Ra
than from those infected with the control virus A/WSN/33.
Furthermore, the mice infected with equivalent amounts
of virus were killed more quickly by the virus in which the
M2 protein was not phosphorylated. In future work, we
intend to determine the basis for this difference.
METHODS AND MATERIALS
Viruses and cells
Influenza viruses A/WSN/33, A/PR/8/34, A/Eng/42/72,
and B/Lee/40 were cultivated in 10-day-old embryonated
chicken eggs at 37°C or 34°C for influenza type A or B
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viruses, respectively. Allantoic fluids were harvested 2
days after inoculation. Virus stocks were titrated on
MDCK cells and stored at 270°C. MDCK and MDBK
cells were routinely passaged in Eagle’s minimal essen-
tial medium (EMEM) (GIBCO BRL) supplemented with
10% heat-inactivated FCS (GIBCO BRL).
DNA cloning
Segment 7 of A/WSN/33 was cloned as a cDNA be-
tween the EcoRI and XbaI restriction sites of the multiple
cloning site of pUC19, after RT-PCR from vRNA using
primers EKFlu (59-gcgcgaattcctcttcgAGCAAAAGCAG-39)
and AllfluPCR (59-aagcttctagaattaaccctcactaaaAGTAGA-
AACAAGGTAGTTTTTTACTCGAGCTCTATG-39; lowercase
letters denote noninfluenza residues included for cloning
purposes), giving the plasmid pT3WSNMMut1. In vitro
transcription of Ksp632I linearized pT3WSNMMut1 by T3
polymerase produces an RNA with an authentic segment
7 terminus and a silent mutation at nucleotide 96 (G3C),
which creates an SacI restriction enzyme site as a tag.
To create cDNAs encoding M2 proteins with mutations of
serine to alanine at amino acids 64 and 71, or 64 or 71
alone, PCR mutagenesis was performed on template
pT3WSNMMut1 using primers M2P-(59-TTCAAATCATTT-
ATCGTCGCTTTAAATACGGTTTGAAAAGAGGGCCTT/GCT-
ACGGAAGGAGTGCCAGAGT/GCTATG-39) and AllfluPCR.
The products were digested with NsiI and SacI and
cloned into pT3WSNMMut1 digested with the same en-
zymes. Mutations were confirmed by sequencing and
plasmids containing one or both mutations were named
pT3WSNMP-1, pT3WSNMP-2, and pT3WSNMP-1–2.
Cell lines for the expression of A/WSN/33 M2 and
the mutant proteins P-2 and P-1–2
The plasmid pT3WSNMMut1 or plasmids containing
the mutations encoding serine-to-alanine changes de-
scribed above were used as template for PCR with prim-
ers M2START (59-cccgggtctagatcATGAGTCTTTCTAACC-
GAGGTCGAAACGCCTATCAGAAACGAATGGGGGTGC-39)
and M2STOP (59-cccgggggatccgaattcTTACTCCAGCTCT-
ATG-39), generating cDNAs corresponding to the M2
spliced mRNAs. These products were subcloned into the
mammalian expression vector pEE6.hcmv.Neo (Bebbing-
ton, 1991) between the XbaI and EcoRI restriction en-
zyme sites downstream of the hCMV promoter.
MDCK cells were transfected using Pfx-2 lipofection
reagent (InVitrogen) with 2 mg of pEE6.Neo.M2,
pEE6.Neo.P-1M2, pEE6.Neo.P-2M2, or pEE6.Neo.P-1-2M2
encoding the wild-type M2 or the phosphorylation mu-
tants P-1, P-2, and P-1-2 (Fig. 1b). Stably expressing
colonies were selected in EMEM supplemented with
10% FCS and 500 mg/ml geneticin sulfate (GIBCO BRL).
Expressing colonies were screened by blue cell assay
(Ward et al., 1994) using an anti-M2 monoclonal antibody,
14C2 (kindly supplied by R. A. Lamb), diluted in PBS plus
0.5% bovine serum albumin (BSA) and 0.02% sodium
azide as a primary antibody and a b-galactosidase-con-
jugated anti-mouse secondary antibody (Harlan Sera-
lab), followed by incubation with X-gal substrate. Colo-
nies expressing exogenous M2 at levels comparable to
those seen in infected cells were amplified and main-
tained in selective media.
Preparation of whole cell lysates and infected cell
lysates
For whole cell lysates, MDCK and MDCK cells ex-
pressing the wild-type and mutant M2s were grown to
confluency in 35-mm dishes. Cells were washed in ice-
cold PBS and incubated with lysis buffer (100 mM NaCl,
50 mM iodoacetamide, 1% Nonidet-P40, 0.1% SDS, 0.5%
sodium deoxycholate, 20 mM Tris–HCl, pH 7.5) on ice for
10 min.
For infected cell lysates, MDCK cells were infected at
an m.o.i. of 3 with A/PR/8/34 or B/Lee/40 and incubated
for 12 h at 37°C or 34°C, respectively. Lysates were
stored at 220°C. B/Lee/40 was amplified in the pres-
ence of 2.5 mg/ml tunicamycin (Sigma).
Generation and purification of virus incorporating
exogenous M2 proteins
MDCK cells expressing wild type or the mutant M2s
were infected with A/PR/8/34 or B/Lee/40 at an m.o.i. of
3. Virus was allowed to adsorb for 1 h at the appropriate
temperature. Cells were washed twice in PBS and incu-
bated in serum-free EMEM including 2 mg/ml trypsin
(Worthington Biochemical). After incubation at the appro-
priate temperature for 48 h, supernatants containing re-
leased virus were harvested. Cell debris was removed
by centrifugation at 10,500g in a benchtop microfuge for
15 min. Virus was pelleted from the supernatants through
cushions of 30% sucrose in NTE (100 mM NaCl, 10 mM
Tris–HCl, pH 7.4, 1 mM EDTA) by ultracentrifugation at
45,000 rpm using an SW55 rotor (Beckman) at 4°C for 90
min. Virus was resuspended in TMK (10 mM KCl, 1.5 mM
MgCl2, 10 mM Tris–HCl, pH 7.4) containing 1 mM phe-
nylmethylsulfonyl fluoride (Sigma) and 2 mg/ml aprotinin
(Sigma) and stored at 220°C until analysis.
Analysis of virus to detect the incorporation of
exogenous M2
Purified virus and cell lysates were analyzed by
SDS–PAGE using 15% or 20% acrylamide gels under
nonreducing or reducing conditions for detection of
M2 and NB, respectively. Proteins were transferred
onto PVDF membranes (Immobilon P; Millipore) and
probed either for M2, with 14C2 diluted in 2% Marvel
milk protein in PBS containing 0.1% Tween 20, or for
NB, using a rabbit polyclonal antiserum generated to a
histidine-tagged cytoplasmic tail fragment of NB ex-
pressed in Escherichia coli. Primary antibodies bound
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to M2 or NB were detected with anti-mouse or anti-
rabbit HRPO-conjugated secondary antibodies (Amer-
sham), respectively. Proteins were visualized using an
ECL detection system (Amersham) and exposure to
photographic film.
Cell surface expression of M2 and mutant M2
proteins in polarized epithelial cells
MDCK cells stably expressing the wild-type M2 and
the phosphorylation mutants were grown to confluency
on DATA filters (0.4-mm pore size; Costar). Blue cell
assay was performed on unfixed, nonpermeabilized
cells. The cells were probed on either the apical or
basolateral surface for expression of the M2 proteins
using 14C2 as a primary antibody, followed by a second-
ary anti-mouse antibody conjugated to b-galactosidase
(Harlan Sera-lab). Finally, cells were incubated in X-Gal
substrate at 37°C (Ward et al., 1994).
Generation and identification of transfectant viruses
RNP transfections were performed in MDBK cells es-
sentially as described previously (Enami et al., 1990;
Enami and Palese, 1991). A/Eng/42/72 was selected from
a panel of potential H3N2 helper viruses because it
showed clear inhibition of plaque formation in the pres-
ence of 100 mM amantadine HCl (Sigma). The trans-
fected segment 7 is derived from the A/WSN/33 strain,
which encodes an M2 ion channel that is naturally aman-
tadine resistant. After three rounds of plaque purification
of potential transfectant viruses in the presence of aman-
tadine, individual plaques were amplified in MDCK cells
to produce virus stocks. Viral RNA was extracted from 3
ml of tissue culture supernatant as described previously
(Stevens and Barclay, 1998). Viral RNA was subjected to
RT-PCR using primer M2RT (59-GGCTATGGAGCAAATG-
GCTGG-39) complementary to nucleotides 587–607 of
segment 7 for RT and primers M2seq (59-CCTATCA-
GAAACGAATGGGGG-39) complementary to nucleotides
742–772 with Allflupcr for PCR. The product of 315 bp was
digested with SacI, and cleavage into two fragments of
58 and 257 bp confirmed the presence of the restriction
site tag and that the vRNA was derived from a transfec-
tant virus.
32P-Orthophosphate and 35S-methionine and -cysteine
labeling and immunoprecipitation of virus
MDCK cells were incubated overnight in phosphate-
free EMEM and then infected with virus at an m.o.i. of
.3. At 5 h p.i., 5 mCi of 32P-orthophosphate was added
to the medium, and incubation continued for an addi-
tional 3 h. For methionine and cysteine labeling, at 4 h
p.i., duplicate dishes were incubated in methionine- and
cysteine-free media (Sigma) for 1 h. Then, 10 mCi of
35S-methionine and -cysteine was added, and incubation
was continued for an additional 3 h.
At 8 h p.i., cells were washed with either phosphate-
free EMEM or PBS for orthophosphate or methionine–
cysteine labeling, respectively, and lysed in a total vol-
ume of 500 ml of lysis buffer. Cell lysates were passed
three times through a fine-gauge syringe, and nuclei and
membranes were pelleted by centrifugation at 80,000
rpm in a Tw2 rotor of a Beckman benchtop ultracentri-
fuge for 30 min at 4°C. Next, 200 ml of clarified cytoplas-
mic extracts were incubated at 4°C overnight with either
2 ml of 14C2 or 5 ml of anti-NP monoclonal antibody
(Harlan Sera-lab). Protein G–agarose (30 ml) previously
washed in lysis buffer was added, and tubes were ro-
tated for 30 min at room temperature. Agarose beads, to
which antibodies and antigens were bound, were
washed five times with lysis buffer and resuspended in
30 ml of Laemmli’s buffer containing the reducing agent
b-mercaptoethanol. Immune precipitates were analyzed
by 15% SDS–PAGE. Gels were treated with Amplify (Am-
ersham) before drying and exposure to b-max hyperfilm
(Amersham).
Generation of the reassortant virus Ra lacking
phosphorylation sites in M2
A virus with seven RNA segments from A/WSN/33 and
segment 7 containing the engineered mutation was gen-
erated by reassorting the transfectant virus with ts51
(obtained from Dr. Gary Whittaker, Cornell University).
Ts51 is a derivative of A/WSN/33 that contains a point
mutation in the M1 gene, rendering the virus temperature
sensitive (Whittaker et al., 1995). The transfectant virus
was exposed to UV irradiation (wavelength 220 nm) for
20 min at a distance of 10 cm to destroy infectivity and,
in particular, target the large RNA segments. This prep-
aration was used to infect MDCK cells that had previ-
ously been infected with a high m.o.i. of ts 51 virus. After
overnight incubation at 39°C, the supernatants were
plaqued in MDBK cells. Plaques were picked and ampli-
fied and then screened by RT-PCR for the presence of the
SacI tag and by analysis of protein migration by SDS–
PAGE to confirm that only segment 7 had been trans-
ferred (data not shown).
Growth of the Ra virus in MDBK cells
MDBK cells were infected with the Ra virus and
A/WSN/33 control virus at an m.o.i. of 0.001 and incu-
bated at 37°C. Culture supernatants were harvested at
various times after infection, and the titer of released
virus was established by plaque assay in MDBK cells.
Growth of the Ra virus in vivo
Six-week-old Balb/c mice were inoculated intranasally
under halothane anaesthesia with 7.5 3 105 pfu of the Ra
virus or A/WSN/33 in a volume of 25 ml. The weight and
disease status of individual mice were monitored over an
7-day period. On day 3 after virus administration, five
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mice infected with each virus were killed by exposure to
carbon dioxide, and the lungs were removed for virus
quantification. Lung homogenates were prepared by
grinding in the presence of ,100 mm sterile glass beads
(Sigma) and 250 ml of PBS containing 0.5% BSA. Homog-
enates of each lung were clarified by centrifugation at
10,500g in a microfuge for 5 min, and the amount of virus
was titrated by infectivity assay on MDBK cells. TCID50
values were calculated using the Spearman–Karber for-
mula. Statistical significance was calculated using Stu-
dent’s unpaired t test.
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